|
|
| NCID
Board of Scientific Counselors |
| Updated
February 2004 |
| About
the Board of Scientific Counselors |
| 
Through
the broad and diverse expertise represented by its membership, the
Board of Scientific Counselors (BSC) adds an essential dimension
to the CDC and National Center for Infectious Disease (NCID) goal
of preventing and controlling infectious disease threats in the
United States and worldwide. The board’s 21 voting members
are among our country’s most elite public health leaders from
academia, private industry, private practice, medical and public
health associations, the general public, as well as local, state,
and other federal agencies. The board is further enhanced by the
(non-voting) participation of liaison representatives from Canada
and Mexico. Members are invited to serve for two, three, or four-year
terms, which overlap to lend continuity to the organization. Typically,
the board meets in public session twice a year.
The Board’s
advice is consistently valuable to the NCID Director, NCID scientists,
and program managers. The Board has contributed markedly to NCID’s
success in:
- improving
emergency response capacities
- enhancing
preparedness against emerging and re-emerging diseases and related
threats
- strengthening
an expanding network of state and local health departments
- innovating
approaches for improved detection and control of infectious diseases
- implementing
science-based programs to prevent the spread of infectious diseases
- supporting
research to identify, characterize, and combat emerging infectious
disease threats.
During the next
two years the Board will focus on refining the nation’s century-old
public health system to better address the emergence of new infectious
disease threats, both natural and intentional. CDC and NCID will
continue to consult the Board in the development of strategic plans
to meet contemporary public health challenges. Specifically, advice
from the Board will add substantial value to CDC’s new Strategic
Direction Initiative, titled "Creating the Future of CDC for
the 21st Century.” Input from both internal and external partners,
including the Board, will be fundamental to the success of this
initiative.
|
Bond,
Enriqueta C., Ph.D.
President
The Burroughs Wellcome Fund
Research Triangle Park, NC |
Ostroff,
Stephen M., M.D.
Deputy Director
National Center for Infectious Diseases
Centers for Disease Control and Prevention
Atlanta,
GA |
Borne, Ronald
F., Ph.D.
Professor of Medicinal Chemistry and Associate Director
Laboratory for Applied Drug Design and Synthesis
University of Mississippi
University, MS
Downes,
Frances Pouch, Dr.P.H., M.P.H.
Administrator
Bureau of Laboratories
Michigan Department of Community Health
Lansing, MI
Ferraro,
Mary Jane, Ph.D., M.P.H.
Director, Microbiology Laboratories
Massachusetts General Hospital
Boston, MA
Hinthorn,
Daniel R., M.D.
Professor of Internal Medicine, Pediatrics and Family Medicine
Chief of Infectious Diseases
University of Kansas Medical Center
Kansas City, KS
King, Lonnie
J., D.V.M.
Dean
College of Veterinary Medicine
Michigan State University
East Lansing, MI
Lemon, Stanley
M., M.D.
Dean of Medicine
University of Texas Medical Branch
Galveston, TX
Mejicano,
George Charles, M.D.
Associate Professor of Medicine
University of Wisconsin Medical School
Madison, WI
Neill, Marguerite
A., M.D.
Division of Infectious Diseases
Memorial Hospital of Rhode Island
Pawtucket, RI
Okhuysen,
Pablo Christian, M.D.
Associate Professor of Medicine
University of Texas Medical School at Houston
Division of Infectious Diseases
Houston, TX
Quinlisk,
M. Patricia, M.D., M.P.H.
State Epidemiologist/Medical Director
Iowa Department of Public Health
Des Moines, IA
Rabinovich,
N. Regina, M.D.
Director, Infectious Diseases
Global Health Program
Bill and Melinda Gates Foundation
Seattle, WA
Rodriguez–Garcia,
Rosalia, Ph.D., M.S.C.
Past Chair, Department of International Public Health (Founding Chair)
School of Public Health and Health Services
George Washington University
McLean, VA
Sanchez,
Eduardo J., M.D., M.P.H.
Commissioner
Texas Department of Health
Austin, TX
Stamm, Walter
E., M.D.
Head
Division of Infectious Diseases
University of Washington
Seattle, WA
Wertz, Gail
W., Ph.D.
Professor
Department of Microbiology
University of Alabama School of Medicine
Birmingham, AL
Woollett,
Gillian R., M.A., D.Phil.
Vice President
Science and Regulatory Affairs
Biotechnology Industry Organization
Washington, DC
Bennett,
John E., M.D.
Head
Clinical Mycology Section
Laboratory of Clinical Investigations
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, MD
Goodman,
Jesse L., M.D., M.P.H.
Acting Deputy Director
Center for Biologics Evaluation and Research
Food and Drug Administration
Rockville, MD
Heilman,
Carole, Ph.D.
Director, Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, MD
Oster, Charles
N., M.D.
Chief, Department of Medicine
Walter Reed Army Medical Center
Washington, D.C.
Contreras-Theurel,
Rosalinda, Ph.D.
Directora General
Centro de Investigación y de Estudios Avanzados
Mexico, D.F.
Mexico
Gully, Paul
R., MB, ChBm, FRCPC
Senior Director General, Centre for Infectious Disease Prevention and
Disease Control
Population and Public Health Branch
Ottawa, Ontario
Canada
Weinstein,
Robert A., M.D.
Chairman, Division of Infectious Diseases
Cook County Hospital
Chicago, IL
|
